Market research
9776.TSE Sapporo Clinical Laboratory Inc
TSE JPY Healthcare
Latest close
As of 28 Mar 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 35K
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- 1.2%
- Beta
- 0.35
Profile
Instrument facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- ISIN
- JP3321100004
- Market cap
- 35K
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- 1.2%
- Beta
- 0.35
About
About Sapporo Clinical Laboratory Inc
Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company engages in contract and agency services for various clinical testing and public health testing, as well as food hygiene testing; sales and maintenance of software, such as clinical testing systems; management of dispensing pharmacies; and pharmaceutical wholesale. It also offers pathological examination, holter testing, radiation management, clinic opening support, test result inquiry services, and electronic medical record linkage. The company was incorporated in 1965 and is headquartered in Sapporo, Japan.
Research context
Sapporo Clinical Laboratory Inc appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 9776.TSE discussion.
5 years, 6 months ago
Sapporo Clinical Laboratory Inc is currently in a long term uptrend where the price is trading 5.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Sapporo Clinical Laboratory Inc's total revenue rose by 2.5% to $5B since the same quarter in the previous year.
Its net income has increased by 52.0% to $258M since the same quarter in the previous year.
Based on the above factors, Sapporo Clinical Laboratory Inc gets an overall score of 4/5.